Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-028352
Filing Date
2012-05-14
Accepted
2012-05-14 11:09:36
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v312502_10q.htm 10-Q 299362
2 CERTIFICATION v312502_ex31.htm EX-31 7672
3 CERTIFICATION v312502_ex32.htm EX-32 5693
  Complete submission text file 0001144204-12-028352.txt   1610400

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT iccc-20120331.xml EX-101.INS 140103
5 XBRL TAXONOMY EXTENSION SCHEMA iccc-20120331.xsd EX-101.SCH 14959
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20120331_cal.xml EX-101.CAL 22941
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20120331_def.xml EX-101.DEF 63737
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20120331_lab.xml EX-101.LAB 147722
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20120331_pre.xml EX-101.PRE 88953
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 12837074
SIC: 2835 In Vitro & In Vivo Diagnostic Substances